• LC-MS identifies oncogene Rab33B in ischemic brain tissue
    Up-regulation of the oncogene Rab33B is detected in ischemic brain tissue using LC-MS

HPLC, UHPLC

LC-MS identifies oncogene Rab33B in ischemic brain tissue

Nov 26 2010

Research conducted using liquid chromatography-mass spectrometry (LC-MS) has detected higher levels of the oncogene Rab33B in brain tissue following an ischemic cerebral event.

Ischemia occurs when oxygen is unable to reach the tissue in the brain and is the most common cause of stroke.

Typically, it is caused by the blockage of a vessel elsewhere in the body, unlike haemorrhagic stroke which occurs when weakened vessels within the brain itself bleed into the tissue.

A study published in Experimental & Translational Stroke Medicine reports the findings of LC-MS research into the after-effects of ischemic attack.

Specifically, the scientists focused on levels of Rab33B, a known oncogene which, if expressed to a significantly high degree, can be associated with the formation of tumours.

They found a time-dependent link between ischemia in the brain and the number of cells found to be positive for content of Rab33B, with a general up-regulation of the oncogene throughout the ischemic striatum.

Digital Edition

Chromatography Today - Buyers' Guide 2022

October 2023

In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...

View all digital editions

Events

NGVS 2024

May 23 2024 Beijing, China

Analiza

May 28 2024 Tel Aviv, Israel

HTC-18

May 28 2024 Leuven, Belgium

PREP 2024

May 28 2024 Philadelphia, PA, USA

CISILE 2024

May 29 2024 Beijing, China

View all events